These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 27030674)

  • 1. Staufen1 impairs stress granule formation in skeletal muscle cells from myotonic dystrophy type 1 patients.
    Ravel-Chapuis A; Klein Gunnewiek A; Bélanger G; Crawford Parks TE; Côté J; Jasmin BJ
    Mol Biol Cell; 2016 Jun; 27(11):1728-39. PubMed ID: 27030674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The RNA-binding protein Staufen1 is increased in DM1 skeletal muscle and promotes alternative pre-mRNA splicing.
    Ravel-Chapuis A; Bélanger G; Yadava RS; Mahadevan MS; DesGroseillers L; Côté J; Jasmin BJ
    J Cell Biol; 2012 Mar; 196(6):699-712. PubMed ID: 22431750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Staufen1 Regulates Multiple Alternative Splicing Events either Positively or Negatively in DM1 Indicating Its Role as a Disease Modifier.
    Bondy-Chorney E; Crawford Parks TE; Ravel-Chapuis A; Klinck R; Rocheleau L; Pelchat M; Chabot B; Jasmin BJ; Côté J
    PLoS Genet; 2016 Jan; 12(1):e1005827. PubMed ID: 26824521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MBNL1 is the primary determinant of focus formation and aberrant insulin receptor splicing in DM1.
    Dansithong W; Paul S; Comai L; Reddy S
    J Biol Chem; 2005 Feb; 280(7):5773-80. PubMed ID: 15546872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Misregulation of calcium-handling proteins promotes hyperactivation of calcineurin-NFAT signaling in skeletal muscle of DM1 mice.
    Ravel-Chapuis A; Bélanger G; Côté J; Michel RN; Jasmin BJ
    Hum Mol Genet; 2017 Jun; 26(12):2192-2206. PubMed ID: 28369518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short antisense-locked nucleic acids (all-LNAs) correct alternative splicing abnormalities in myotonic dystrophy.
    Wojtkowiak-Szlachcic A; Taylor K; Stepniak-Konieczna E; Sznajder LJ; Mykowska A; Sroka J; Thornton CA; Sobczak K
    Nucleic Acids Res; 2015 Mar; 43(6):3318-31. PubMed ID: 25753670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. (CTG)n repeat-mediated dysregulation of MBNL1 and MBNL2 expression during myogenesis in DM1 occurs already at the myoblast stage.
    André LM; van Cruchten RTP; Willemse M; Wansink DG
    PLoS One; 2019; 14(5):e0217317. PubMed ID: 31116797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In silico discovery of substituted pyrido[2,3-d]pyrimidines and pentamidine-like compounds with biological activity in myotonic dystrophy models.
    González ÀL; Konieczny P; Llamusi B; Delgado-Pinar E; Borrell JI; Teixidó J; García-España E; Pérez-Alonso M; Estrada-Tejedor R; Artero R
    PLoS One; 2017; 12(6):e0178931. PubMed ID: 28582438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Furamidine Rescues Myotonic Dystrophy Type I Associated Mis-Splicing through Multiple Mechanisms.
    Jenquin JR; Coonrod LA; Silverglate QA; Pellitier NA; Hale MA; Xia G; Nakamori M; Berglund JA
    ACS Chem Biol; 2018 Sep; 13(9):2708-2718. PubMed ID: 30118588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hammerhead ribozyme-mediated destruction of nuclear foci in myotonic dystrophy myoblasts.
    Langlois MA; Lee NS; Rossi JJ; Puymirat J
    Mol Ther; 2003 May; 7(5 Pt 1):670-80. PubMed ID: 12718910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small molecule kinase inhibitors alleviate different molecular features of myotonic dystrophy type 1.
    Wojciechowska M; Taylor K; Sobczak K; Napierala M; Krzyzosiak WJ
    RNA Biol; 2014; 11(6):742-54. PubMed ID: 24824895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bruno-3 regulates sarcomere component expression and contributes to muscle phenotypes of myotonic dystrophy type 1.
    Picchio L; Legagneux V; Deschamps S; Renaud Y; Chauveau S; Paillard L; Jagla K
    Dis Model Mech; 2018 May; 11(5):. PubMed ID: 29716962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sense and Antisense DMPK RNA Foci Accumulate in DM1 Tissues during Development.
    Michel L; Huguet-Lachon A; Gourdon G
    PLoS One; 2015; 10(9):e0137620. PubMed ID: 26339785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. hnRNP L is essential for myogenic differentiation and modulates myotonic dystrophy pathologies.
    Alexander MS; Hightower RM; Reid AL; Bennett AH; Iyer L; Slonim DK; Saha M; Kawahara G; Kunkel LM; Kopin AS; Gupta VA; Kang PB; Draper I
    Muscle Nerve; 2021 Jun; 63(6):928-940. PubMed ID: 33651408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MBNL1 and CUGBP1 modify expanded CUG-induced toxicity in a Drosophila model of myotonic dystrophy type 1.
    de Haro M; Al-Ramahi I; De Gouyon B; Ukani L; Rosa A; Faustino NA; Ashizawa T; Cooper TA; Botas J
    Hum Mol Genet; 2006 Jul; 15(13):2138-45. PubMed ID: 16723374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expansion of CUG RNA repeats causes stress and inhibition of translation in myotonic dystrophy 1 (DM1) cells.
    Huichalaf C; Sakai K; Jin B; Jones K; Wang GL; Schoser B; Schneider-Gold C; Sarkar P; Pereira-Smith OM; Timchenko N; Timchenko L
    FASEB J; 2010 Oct; 24(10):3706-19. PubMed ID: 20479119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immortalized human myotonic dystrophy muscle cell lines to assess therapeutic compounds.
    Arandel L; Polay Espinoza M; Matloka M; Bazinet A; De Dea Diniz D; Naouar N; Rau F; Jollet A; Edom-Vovard F; Mamchaoui K; Tarnopolsky M; Puymirat J; Battail C; Boland A; Deleuze JF; Mouly V; Klein AF; Furling D
    Dis Model Mech; 2017 Apr; 10(4):487-497. PubMed ID: 28188264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of MTMR1 expression and correlation with muscle pathological features in juvenile/adult onset myotonic dystrophy type 1 (DM1) and in myotonic dystrophy type 2 (DM2).
    Santoro M; Modoni A; Masciullo M; Gidaro T; Broccolini A; Ricci E; Tonali PA; Silvestri G
    Exp Mol Pathol; 2010 Oct; 89(2):158-68. PubMed ID: 20685272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colocalization of muscleblind with RNA foci is separable from mis-regulation of alternative splicing in myotonic dystrophy.
    Ho TH; Savkur RS; Poulos MG; Mancini MA; Swanson MS; Cooper TA
    J Cell Sci; 2005 Jul; 118(Pt 13):2923-33. PubMed ID: 15961406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of Staufen1 in DM1 mouse skeletal muscle exacerbates dystrophic and atrophic features.
    Crawford Parks TE; Marcellus KA; Péladeau C; Jasmin BJ; Ravel-Chapuis A
    Hum Mol Genet; 2020 Aug; 29(13):2185-2199. PubMed ID: 32504084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.